1. Home
  2. PODD vs PFG Comparison

PODD vs PFG Comparison

Compare PODD & PFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • PFG
  • Stock Information
  • Founded
  • PODD 2000
  • PFG 1879
  • Country
  • PODD United States
  • PFG United States
  • Employees
  • PODD N/A
  • PFG N/A
  • Industry
  • PODD Medical/Dental Instruments
  • PFG Specialty Insurers
  • Sector
  • PODD Health Care
  • PFG Finance
  • Exchange
  • PODD Nasdaq
  • PFG Nasdaq
  • Market Cap
  • PODD 17.2B
  • PFG 16.3B
  • IPO Year
  • PODD 2007
  • PFG N/A
  • Fundamental
  • Price
  • PODD $257.00
  • PFG $78.84
  • Analyst Decision
  • PODD Buy
  • PFG Hold
  • Analyst Count
  • PODD 17
  • PFG 14
  • Target Price
  • PODD $302.56
  • PFG $83.64
  • AVG Volume (30 Days)
  • PODD 695.5K
  • PFG 1.8M
  • Earning Date
  • PODD 05-08-2025
  • PFG 04-24-2025
  • Dividend Yield
  • PODD N/A
  • PFG 3.75%
  • EPS Growth
  • PODD 96.55
  • PFG N/A
  • EPS
  • PODD 5.78
  • PFG 4.68
  • Revenue
  • PODD $2,071,600,000.00
  • PFG $15,770,300,000.00
  • Revenue This Year
  • PODD $20.53
  • PFG $0.78
  • Revenue Next Year
  • PODD $17.42
  • PFG $4.32
  • P/E Ratio
  • PODD $44.43
  • PFG $16.85
  • Revenue Growth
  • PODD 22.07
  • PFG 5.84
  • 52 Week Low
  • PODD $160.19
  • PFG $68.39
  • 52 Week High
  • PODD $289.46
  • PFG $91.98
  • Technical
  • Relative Strength Index (RSI)
  • PODD 50.41
  • PFG 56.97
  • Support Level
  • PODD $252.88
  • PFG $72.21
  • Resistance Level
  • PODD $260.96
  • PFG $77.44
  • Average True Range (ATR)
  • PODD 7.68
  • PFG 1.79
  • MACD
  • PODD 1.34
  • PFG 0.94
  • Stochastic Oscillator
  • PODD 65.40
  • PFG 93.63

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About PFG Principal Financial Group Inc

Principal Financial Group Inc is a financial services provider. It offers various financial products and services including retirement, asset management, and workplace benefits and protection solutions to individuals and institutional clients. The company, along with its subsidiaries, operates in the following reportable segments; Retirement and Income Solutions, Principal Asset Management, and Benefits and Protection. Maximum revenue is generated from the Retirement and Income Solutions segment which provides workplace savings and retirement solutions, banking, trust and custodial services, individual variable annuities (including RILAs), pension risk transfer, and investment services to businesses, their employees, and other individuals.

Share on Social Networks: